Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study
Authors:
- 15 June 2019
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (1) , 104-111
Abstract
To describe the health-related quality of life (HRQoL) and fatigue burden among adult patients with immune thrombocytopenia (ITP) in China and determine whether they vary with disease phase. This is a cross-sectional, multi-centre observational study of adult ITP patients and the general population. Participants completed the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F). We compared HRQoL and fatigue between ITP patients and the general population, overall and by disease phase (newly diagnosed, persistent, and chronic), using propensity score matching. 203 Patients and 269 members of the general population were recruited. Thirty-six ITP patients (17.7%) were newly diagnosed, 46 (22.7%) were persistent, and 121 (59.6%) were chronic. Compared with the general population, ITP patients had impaired HRQoL and greater fatigue burden. The persistent ITP group showed the largest number of SF-36 scales exceeding the minimally important difference: physical functioning [− 10.5; 95% confidence interval (CI) − 24.5 to 3.5; P < 0.001], role physical (− 16.7; 95% CI − 36.4 to 3.0; P < 0.001), social functioning (− 15.6; 95% CI − 34.5 to 3.3; P < 0.001), and role emotional (− 12.1; 95% CI − 26.0 to 1.8; P < 0.001). Chronic ITP patients had the worst FACIT-F scores (36.89 ± 5.21). Higher fatigue severity was associated with lower physical and mental HRQoL. The HRQoL and fatigue burden of Chinese adult patients with ITP vary by disease phase. Persistent ITP patients were the most vulnerable subgroup in terms of HRQoL, while chronic ITP patients bear the heaviest fatigue burden.Keywords
Funding Information
- Opening Foundation of Jiangsu Branch of China Academy of Chinese Medical Sciences (FY201702)
This publication has 18 references indexed in Scilit:
- Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND studyAmerican Journal of Hematology, 2018
- Chinese guidelines for treatment of adult primary immune thrombocytopeniaInternational Journal of Hematology, 2018
- Pathogenesis of immune thrombocytopeniaAutoimmunity Reviews, 2017
- Second-line therapies in immune thrombocytopeniaHematology-American Society Hematology Education Program, 2016
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: replyJournal of Thrombosis and Haemostasis, 2015
- Fatigue in immune thrombocytopeniaBritish Journal of Haematology, 2015
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Self‐reported health‐related quality of life in adults with chronic immune thrombocytopenic purpuraAmerican Journal of Hematology, 2007
- Health‐related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross‐sectional survey in ChinaEuropean Journal of Haematology, 2007
- Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisationJournal of Epidemiology and Community Health, 2003